Previous Article | Next Article ![]()
J. Virol., 10 1997, 7295-7299, Vol 71, No. 10
C Ardavin, F Luthi, M Andersson, L Scarpellino, P Martin, H Diggelmann and H Acha- Orbea
Mouse mammary tumor virus (MMTV) infects B lymphocytes and expresses a
superantigen on the cell surface after integration of its reverse-
transcribed genome. Superantigen-dependent B- and T-cell activation becomes
detectable 2 to 3 days after infection. We show here that before this
event, B cells undergo a polyclonal activation which does not involve
massive proliferation. This first phase of B-cell activation is T cell
independent. Moreover, during the first phase of activation, when only a
small fraction of B cells is infected by MMTV(SW), viral DNA is detected
only in activated B cells. Such a B- cell activation is also seen after
injection of murine leukemia virus but not after injection of vaccinia
virus, despite the very similar kinetics and intensity of the immune
response. Since retroviruses require activated target cells to induce
efficient infection, these data suggest that the early polyclonal
retrovirus-induced target cell activation might play an important role in
the establishment of retroviral infections.
Copyright © 1997, American Society for Microbiology
Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model
Department of Cell Biology, Faculty of Biology, Complutense University, Madrid, Spain.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|